Antiestrogens prescribed to reduce breast cancer risk or recurrence can have undesirable musculoskeletal side effects that may lead to early discontinuation of therapy. Previous studies have not focused on nurse-led assessmen.
Keywords: antiestrogen; breast cancer survivor; musculoskeletal; patient education; quality of life.